Editorial Comment to "The poor antitumor effect of pembrolizumab in advanced upper urothelial carcinoma with renal parenchymal invasion". Kikuchi E, Hayakawa N. Int J Urol 2023;30:786-787.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kikuchi E, Hayakawa N. Editorial Comment to "The poor antitumor effect of pembrolizumab in advanced upper urothelial carcinoma with renal parenchymal invasion". Int J Urol 2023;30:786-787.
PMID: 37461821